Ryoichi Kase

1.5k total citations
46 papers, 1.2k citations indexed

About

Ryoichi Kase is a scholar working on Physiology, Molecular Biology and Genetics. According to data from OpenAlex, Ryoichi Kase has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Physiology, 26 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Ryoichi Kase's work include Lysosomal Storage Disorders Research (27 papers), Glycosylation and Glycoproteins Research (10 papers) and Carbohydrate Chemistry and Synthesis (9 papers). Ryoichi Kase is often cited by papers focused on Lysosomal Storage Disorders Research (27 papers), Glycosylation and Glycoproteins Research (10 papers) and Carbohydrate Chemistry and Synthesis (9 papers). Ryoichi Kase collaborates with scholars based in Japan, Germany and United States. Ryoichi Kase's co-authors include Hitoshi Sakuraba, Yoshiyuki Suzuki, Toshika Okumiya, Kohji Itoh, Shoken Ishii, Sachiko Kamei, Tadahiko Hazato, Michie Shimmoto, Kouichi Utsumi and Satoshi Ishii and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Ryoichi Kase

46 papers receiving 1.2k citations

Peers

Ryoichi Kase
Lindsay Sweet United States
Joseph W. Hoffmann United States
R P Siraganian United States
Laurie D. Smith United States
Joong-Kook Choi South Korea
Ryoichi Kase
Citations per year, relative to Ryoichi Kase Ryoichi Kase (= 1×) peers Asao Katsume

Countries citing papers authored by Ryoichi Kase

Since Specialization
Citations

This map shows the geographic impact of Ryoichi Kase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryoichi Kase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryoichi Kase more than expected).

Fields of papers citing papers by Ryoichi Kase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryoichi Kase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryoichi Kase. The network helps show where Ryoichi Kase may publish in the future.

Co-authorship network of co-authors of Ryoichi Kase

This figure shows the co-authorship network connecting the top 25 collaborators of Ryoichi Kase. A scholar is included among the top collaborators of Ryoichi Kase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryoichi Kase. Ryoichi Kase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yasui, Fumihiko, Chieko Kai, Masahiro Kitabatake, et al.. (2008). Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV. The Journal of Immunology. 181(9). 6337–6348. 187 indexed citations
2.
Utsumi, Kouichi, Koichi Asahi, Yuichi Komaba, et al.. (2005). Enzyme replacement therapy for Fabry disease: Morphologic and histochemical changes in the urinary sediments. Clinica Chimica Acta. 360(1-2). 103–107. 14 indexed citations
3.
Okumiya, Toshika, Hitoshi Sakuraba, Ryoichi Kase, & Tetsuro Sugiura. (2003). Imbalanced substrate specificity of mutant β-galactosidase in patients with Morquio B disease. Molecular Genetics and Metabolism. 78(1). 51–58. 34 indexed citations
4.
Chiba, Yasunori, Hitoshi Sakuraba, Masaharu Kotani, et al.. (2002). Production in yeast of  -galactosidase A, a lysosomal enzyme applicable to enzyme replacement therapy for Fabry disease. Glycobiology. 12(12). 821–828. 40 indexed citations
5.
Kase, Ryoichi. (2000). Characterization of two alpha-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry disease. Biochemical and Biophysical Research Communications. 1501. 227–235. 3 indexed citations
6.
Kase, Ryoichi, Uwe Bierfreund, Andreas Klein, et al.. (2000). Characterization of two α-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1501(2-3). 227–235. 35 indexed citations
7.
Okumiya, Toshika, Osamu Kawamura, Kohji Itoh, et al.. (1998). Novel missense mutation (M72V) of α-galactosidase gene and its expression product in an atypical fabry hemizygote. Human Mutation. 11(S1). S213–S216. 8 indexed citations
8.
Ishii, Satoshi, Ryoichi Kase, Hitoshi Sakuraba, et al.. (1998). α-Galactosidase transgenic mouse: Heterogeneous gene expression and posttranslational glycosylation in tissues. Glycoconjugate Journal. 15(6). 591–594. 12 indexed citations
9.
Kase, Ryoichi, Michie Shimmoto, Kohji Itoh, et al.. (1998). Immunohistochemical characterization of transgenic mice highly expressing human lysosomal α-galactosidase. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1406(3). 260–266. 12 indexed citations
10.
Ozawa, Hideki, Katsuko Yamashita, Hitoshi Sakuraba, et al.. (1997). Generation and Characterization of Mouse Monoclonal Antibodies Specific for N-Linked Neutral Oligosaccharides of Glycoproteins. Archives of Biochemistry and Biophysics. 342(1). 48–57. 13 indexed citations
12.
Ishii, Seiichi, Ryoichi Kase, Toshika Okumiya, Hitoshi Sakuraba, & Yoshiyuki Suzuki. (1996). Aggregation of the Inactive Form of Human α-Galactosidase in the Endoplasmic Reticulum. Biochemical and Biophysical Research Communications. 220(3). 812–815. 41 indexed citations
13.
Okumiya, Toshika, Shoken Ishii, Takeshi Takenaka, et al.. (1995). Galactose Stabilizes Various Missense Mutants of α-Galactosidase in Fabry Disease. Biochemical and Biophysical Research Communications. 214(3). 1219–1224. 87 indexed citations
14.
Itoh, Kohji, Ryoichi Kase, Michie Shimmoto, et al.. (1995). Protective Protein as an Endogenous Endothelin Degradation Enzyme in Human Tissues. Journal of Biological Chemistry. 270(2). 515–518. 55 indexed citations
15.
Okumiya, Toshika, Satoshi Ishii, Ryoichi Kase, et al.. (1995). ?-Galactosidase gene mutations in Fabry disease: heterogeneous expressions of mutant enzyme proteins. Human Genetics. 95(5). 557–61. 51 indexed citations
16.
Ishii, Satoshi, Ryoichi Kase, Shuji Fujita, et al.. (1994). Human α-galactosidase gene expression: significance of two peptide regions encoded by exons 1–2 and 6. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1204(2). 265–270. 38 indexed citations
17.
Oshima, Akihiro, Kunihiro Yoshida, Kohji Itoh, et al.. (1994). Intracellular processing and maturation of mutant gene products in hereditary ?-galactosidase deficiency (?-galactosidosis). Human Genetics. 93(2). 109–14. 28 indexed citations
18.
Tsuji, Akihiko, Hideaki Nagamune, Kohji Itoh, et al.. (1994). Lysosomal Enzyme Replacement Using α2-Macroglobulin as a Transport Vehicle1. The Journal of Biochemistry. 115(5). 937–944. 3 indexed citations
19.
Kohda, Daisuke, et al.. (1989). A Comparative ^1H NMR Study of Mouse α(1-53) and β(2-53) Epidermal Growth Factors.. 38. 64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026